FSMAX
Price
$98.68
Change
-$2.68 (-2.64%)
Updated
Nov 13 closing price
Net Assets
41.46B
LVOTX
Price
$20.12
Change
-$0.30 (-1.47%)
Updated
Nov 13 closing price
Net Assets
1.11B
Interact to see
Advertisement

FSMAX vs LVOTX

Header iconFSMAX vs LVOTX Comparison
Open Charts FSMAX vs LVOTXBanner chart's image
Fidelity Extended Market Index
Price$98.68
Change-$2.68 (-2.64%)
VolumeN/A
Net Assets41.46B
Lord Abbett Value Opportunities R5
Price$20.12
Change-$0.30 (-1.47%)
VolumeN/A
Net Assets1.11B
FSMAX vs LVOTX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. LVOTX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and LVOTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.5B vs. LVOTX (1.11B). FSMAX pays higher dividends than LVOTX: FSMAX (0.43) vs LVOTX (0.21). FSMAX was incepted earlier than LVOTX: FSMAX (14 years) vs LVOTX (10 years). LVOTX (0.94) is less costly to investors than FSMAX (0.04). LVOTX is a more actively managed with annual turnover of: 33.00 vs. FSMAX (15.00). FSMAX (0) and LVOTX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 6.78 vs. LVOTX (-10.51). FSMAX return over 5 years is better than : 44.78 vs. LVOTX (3.81).
FSMAXLVOTXFSMAX / LVOTX
Total Expense Ratio0.040.944%
Annual Report Gross Expense Ratio0.040.944%
Fund Existence14 years10 years-
Gain YTD11.5981.0391,116%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets41.5B1.11B3,739%
Annual Yield % from dividends0.430.21210%
Returns for 1 year6.78-10.51-65%
Returns for 3 years53.3011.05482%
Returns for 5 years44.783.811,175%
Returns for 10 years108.366.701,618%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CWAN19.791.39
+7.55%
Clearwater Analytics Holdings
UBS39.600.62
+1.59%
UBS Group AG
APUS2.680.01
+0.37%
Apimeds Pharmaceuticals US Inc.
SPH18.73N/A
N/A
Suburban Propane Partners L P
SPIR8.23-0.18
-2.14%
Spire Global